2018 Q1 Form 10-Q Financial Statement

#000087504518000010 Filed on April 24, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $3.131B $2.811B
YoY Change 11.4% 3.08%
Cost Of Revenue $446.0M $384.6M
YoY Change 15.96% 22.88%
Gross Profit $2.685B $2.426B
YoY Change 10.68% 0.51%
Gross Profit Margin 85.76% 86.32%
Selling, General & Admin $501.3M $498.7M
YoY Change 0.52% 0.28%
% of Gross Profit 18.67% 20.56%
Research & Development $496.7M $423.4M
YoY Change 17.31% -3.18%
% of Gross Profit 18.5% 17.45%
Depreciation & Amortization $168.9M $512.0M
YoY Change -67.01% 242.02%
% of Gross Profit 6.29% 21.1%
Operating Expenses $998.0M $922.1M
YoY Change 8.23% -1.34%
Operating Profit $1.535B $1.025B
YoY Change 49.77% -25.66%
Interest Expense $50.50M $63.40M
YoY Change -20.35% 0.16%
% of Operating Profit 3.29% 6.19%
Other Income/Expense, Net -$41.00M -$38.00M
YoY Change 7.89% -28.03%
Pretax Income $1.494B $986.7M
YoY Change 51.38% -25.57%
Income Tax $322.5M $239.2M
% Of Pretax Income 21.59% 24.24%
Net Earnings $1.173B $747.6M
YoY Change 56.89% -23.0%
Net Earnings / Revenue 37.46% 26.6%
Basic Earnings Per Share $5.55 $3.47
Diluted Earnings Per Share $5.54 $3.46
COMMON SHARES
Basic Shares Outstanding 211.4M shares 215.6M shares
Diluted Shares Outstanding 211.7M shares 215.9M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.916B $2.880B
YoY Change 105.42% -19.67%
Cash & Equivalents $4.108B $924.0M
Short-Term Investments $1.808B $1.956B
Other Short-Term Assets $895.9M $1.232B
YoY Change -27.27% 30.9%
Inventory $890.8M $921.6M
Prepaid Expenses
Receivables $1.939B $1.502B
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.20B $6.860B
YoY Change 48.63% -4.74%
LONG-TERM ASSETS
Property, Plant & Equipment $3.335B $2.611B
YoY Change 27.72% 15.58%
Goodwill $4.908B $3.612B
YoY Change 35.89% 23.78%
Intangibles $3.795B $4.104B
YoY Change -7.54% 2.29%
Long-Term Investments $1.580B $4.006B
YoY Change -60.56% -6.23%
Other Assets $380.1M $1.185B
YoY Change -67.91% 8.21%
Total Long-Term Assets $15.89B $14.34B
YoY Change 10.87% 6.4%
TOTAL ASSETS
Total Short-Term Assets $10.20B $6.860B
Total Long-Term Assets $15.89B $14.34B
Total Assets $26.09B $21.20B
YoY Change 23.09% 2.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $345.8M $316.4M
YoY Change 9.29% 16.62%
Accrued Expenses $1.217B $963.0M
YoY Change 26.38% 5.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.000M $562.0M
YoY Change -99.47% 11140.0%
Total Short-Term Liabilities $3.152B $2.993B
YoY Change 5.33% 7.78%
LONG-TERM LIABILITIES
Long-Term Debt $5.929B $5.953B
YoY Change -0.4% -8.92%
Other Long-Term Liabilities $1.640B $688.8M
YoY Change 138.1% -24.85%
Total Long-Term Liabilities $1.640B $688.8M
YoY Change 138.1% -24.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.152B $2.993B
Total Long-Term Liabilities $1.640B $688.8M
Total Liabilities $12.05B $9.729B
YoY Change 23.89% -5.97%
SHAREHOLDERS EQUITY
Retained Earnings $17.33B $14.78B
YoY Change 17.27% 12.15%
Common Stock $100.0K $100.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.977B $2.977B
YoY Change 0.0% 13.99%
Treasury Stock Shares
Shareholders Equity $14.05B $11.48B
YoY Change
Total Liabilities & Shareholders Equity $26.09B $21.20B
YoY Change 23.09% 2.52%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $1.173B $747.6M
YoY Change 56.89% -23.0%
Depreciation, Depletion And Amortization $168.9M $512.0M
YoY Change -67.01% 242.02%
Cash From Operating Activities $1.457B $235.2M
YoY Change 519.52% -76.85%
INVESTING ACTIVITIES
Capital Expenditures $194.7M $210.0M
YoY Change -7.29% 65.48%
Acquisitions
YoY Change
Other Investing Activities -$1.600M $6.600M
YoY Change -124.24% -54.17%
Cash From Investing Activities $1.347B -$744.2M
YoY Change -280.95% -38.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $250.0M $583.6M
YoY Change -57.16%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$268.6M -$901.4M
YoY Change -70.2% 17928.0%
NET CHANGE
Cash From Operating Activities $1.457B $235.2M
Cash From Investing Activities $1.347B -$744.2M
Cash From Financing Activities -$268.6M -$901.4M
Net Change In Cash $2.535B -$1.410B
YoY Change -279.74% 633.06%
FREE CASH FLOW
Cash From Operating Activities $1.457B $235.2M
Capital Expenditures $194.7M $210.0M
Free Cash Flow $1.262B $25.20M
YoY Change 4909.52% -97.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
-3500000 USD
CY2017Q4 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
327000000 USD
CY2018Q1 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
77500000 USD
CY2017Q4 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
327300000 USD
CY2018Q1 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
77200000 USD
CY2017 biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P17M
CY2018Q1 biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P7M
CY2017Q4 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
183700000 USD
CY2018Q1 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
176400000 USD
CY2017Q1 biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
20800000 USD
CY2018Q1 biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
42500000 USD
CY2018Q1 biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
806400000 USD
CY2017Q4 biib Duefromanti Cd20therapeuticprograms
DuefromantiCD20therapeuticprograms
532600000 USD
CY2018Q1 biib Duefromanti Cd20therapeuticprograms
DuefromantiCD20therapeuticprograms
553500000 USD
CY2017Q1 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
-0.021
CY2018Q1 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
0.000
CY2018Q1 biib Interest In Subsidiary
InterestInSubsidiary
1.00
CY2017Q4 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
925500000 USD
CY2018Q1 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
906600000 USD
CY2017Q4 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
48300000 USD
CY2018Q1 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
28500000 USD
CY2017Q1 biib Noncontrollinginterestincreasedecreaseother
Noncontrollinginterestincreasedecreaseother
0 USD
CY2018Q1 biib Noncontrollinginterestincreasedecreaseother
Noncontrollinginterestincreasedecreaseother
200000 USD
CY2018Q1 biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
299700000 USD
CY2018Q1 biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
412500000 USD
CY2017Q1 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
340600000 USD
CY2018Q1 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
443200000 USD
CY2017Q1 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
45400000 USD
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
211007945 shares
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000875045
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
47000000 USD
CY2017Q4 biib Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax
113000000 USD
CY2018Q1 biib Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax
-142000000 USD
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
BIOGEN INC.
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
395500000 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
345800000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1787000000 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1939200000 USD
CY2017Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
206700000 USD
CY2018Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
194600000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1559100000 USD
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1631500000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-319900000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-325200000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-318400000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-303900000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-316900000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97800000 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
48100000 USD
CY2018Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
50400000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
448500000 USD
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
103900000 USD
CY2018Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2017Q4 us-gaap Assets
Assets
23652600000 USD
CY2018Q1 us-gaap Assets
Assets
26090100000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7873300000 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
10195400000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5173000000 USD
CY2018Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3011000000 USD
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
5172500000 USD
CY2018Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3008200000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2300000 USD
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
500000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2800000 USD
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
5173000000 USD
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3300000 USD
CY2018Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3011000000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1123000000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1124200000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2730000000 USD
CY2017Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2115200000 USD
CY2018Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1808000000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
2730000000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2116000000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1809300000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2115200000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1808000000 USD
CY2017Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1200000 USD
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1800000 USD
CY2017Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
1900000 USD
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
9400000 USD
CY2017Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
3057300000 USD
CY2018Q1 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
1200200000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
844600000 USD
CY2018Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
524300000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
279000000 USD
CY2018Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
273700000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2326500000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
924000000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573800000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4108000000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1410400000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2535100000 USD
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1229400000 USD
CY2018Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3773700000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
742300000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1185900000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
100000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1700000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
742200000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1184200000 USD
CY2017Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
159700000 USD
CY2018Q1 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
178200000 USD
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
384600000 USD
CY2018Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
446000000 USD
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
1786000000 USD
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
1596400000 USD
CY2017Q4 us-gaap Debt Current
DebtCurrent
3200000 USD
CY2018Q1 us-gaap Debt Current
DebtCurrent
3300000 USD
CY2017Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6483300000 USD
CY2018Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6188300000 USD
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
76100000 USD
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
53100000 USD
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
595900000 USD
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
2277400000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
122600000 USD
CY2018Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1331100000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
512000000 USD
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
168900000 USD
CY2018Q1 us-gaap Derivative Remaining Maturity1
DerivativeRemainingMaturity1
P12M
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.47
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.55
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.46
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.54
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7900000 USD
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-900000 USD
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.112
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.007
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.014
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.006
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.007
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.004
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.010
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.009
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.007
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.008
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
297700000 USD
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
186700000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2700000 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3400000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
12400000 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7600000 USD
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-10000000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
5600000 USD
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
6700000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
20000000 USD
CY2018Q1 us-gaap Fair Value Measurements Changes In Valuation Techniques
FairValueMeasurementsChangesInValuationTechniques
0
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4385000000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4489200000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
402600000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
330700000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
211200000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
242200000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
255000000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
379500000 USD
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4000000 USD
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1000000 USD
CY2017Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-1600000 USD
CY2018Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
5600000 USD
CY2017Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2400000 USD
CY2018Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-14400000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
4632500000 USD
CY2018Q1 us-gaap Goodwill
Goodwill
4907800000 USD
CY2018Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
270500000 USD
CY2018Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2018Q1 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
4800000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
986700000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1493700000 USD
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
239200000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
322500000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
195700000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
134000000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-195100000 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
257600000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-684200000 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-121800000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
46200000 USD
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2600000 USD
CY2017Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
34300000 USD
CY2018Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
20000000 USD
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
8264600000 USD
CY2018Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
8283700000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3879600000 USD
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3794500000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
63400000 USD
CY2018Q1 us-gaap Interest Expense
InterestExpense
50500000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
157400000 USD
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
148000000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
902700000 USD
CY2018Q1 us-gaap Inventory Net
InventoryNet
890800000 USD
CY2017Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
22800000 USD
CY2018Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
15800000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
162400000 USD
CY2018Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
164300000 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
605700000 USD
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
594300000 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
16700000 USD
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
26700000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
11054500000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
12052600000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23652600000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26090100000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3368200000 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3152100000 USD
CY2017Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
1250000000 USD
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
5935000000 USD
CY2018Q1 us-gaap Long Term Debt
LongTermDebt
5929400000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
-11500000 USD
CY2017Q1 us-gaap Minority Interest
MinorityInterest
-11600000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
-14700000 USD
CY2018Q1 us-gaap Minority Interest
MinorityInterest
-16200000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-901400000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-268600000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-744200000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1346600000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
235200000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1457100000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
747600000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1172900000 USD
CY2017Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 USD
CY2018Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1700000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38000000 USD
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-41000000 USD
CY2017Q4 us-gaap Notes Payable
NotesPayable
5938200000 USD
CY2018Q1 us-gaap Notes Payable
NotesPayable
5932700000 USD
CY2018Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1024700000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1534700000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
636900000 USD
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
653400000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
962000000 USD
CY2018Q1 us-gaap Other Assets Current
OtherAssetsCurrent
895900000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
431600000 USD
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
380100000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1600000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2200000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
1000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-24400000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-23800000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-29000000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44700000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5300000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-100000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
500000 USD
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2901300000 USD
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2571100000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1628700000 USD
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1640000000 USD
CY2017Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-18100000 USD
CY2018Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-26100000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2300000 USD
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1800000 USD
CY2017Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
90000000 USD
CY2018Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
164400000 USD
CY2017Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
6600000 USD
CY2018Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1600000 USD
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
583600000 USD
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
250000000 USD
CY2017Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
302700000 USD
CY2018Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
0 USD
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25500000 USD
CY2018Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
21200000 USD
CY2017Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1256700000 USD
CY2018Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1919200000 USD
CY2017Q1 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 USD
CY2018Q1 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
10000000 USD
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
855200000 USD
CY2018Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2017Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
300000000 USD
CY2018Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
600000000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
210000000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194700000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Taxes
PrepaidTaxes
657600000 USD
CY2018Q1 us-gaap Prepaid Taxes
PrepaidTaxes
587500000 USD
CY2017Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
10400000 USD
CY2018Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2600000 USD
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1884300000 USD
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4068900000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
747500000 USD
CY2018Q1 us-gaap Profit Loss
ProfitLoss
1171200000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3182400000 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3334700000 USD
CY2017Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-6300000 USD
CY2018Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
37400000 USD
CY2017Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
423400000 USD
CY2018Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
496700000 USD
CY2017Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2018Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10000000 USD
CY2017Q1 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2018Q1 us-gaap Restructuring Charges
RestructuringCharges
1600000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15810400000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17334600000 USD
CY2017Q1 us-gaap Revenues
Revenues
2810700000 USD
CY2018Q1 us-gaap Revenues
Revenues
3131100000 USD
CY2017Q1 us-gaap Royalty Revenue
RoyaltyRevenue
25500000 USD
CY2018Q1 us-gaap Royalty Revenue
RoyaltyRevenue
10600000 USD
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2380100000 USD
CY2018Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2523500000 USD
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
498700000 USD
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
501300000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
37000000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
43400000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
12612800000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
14053700000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12598100000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14037500000 USD
CY2018Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
1400000000 USD
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
68200000 USD
CY2018Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
231900000 USD
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2977100000 USD
CY2018Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2977100000 USD
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
761600000 USD
CY2018Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
859300000 USD
CY2017Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
300000 shares
CY2018Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
300000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215900000 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211700000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215600000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211400000 shares
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name View Source Status
0000875045-18-000010-index-headers.html Edgar Link pending
0000875045-18-000010-index.html Edgar Link pending
0000875045-18-000010.txt Edgar Link pending
0000875045-18-000010-xbrl.zip Edgar Link pending
acquirediprd.jpg Edgar Link pending
amortacqintanassets.jpg Edgar Link pending
anticd20therapeuticprograms.jpg Edgar Link pending
biib-20180331.xml Edgar Link completed
biib-20180331.xsd Edgar Link pending
biib-20180331_cal.xml Edgar Link unprocessable
biib-20180331_def.xml Edgar Link unprocessable
biib-20180331_lab.xml Edgar Link unprocessable
biib-20180331_pre.xml Edgar Link unprocessable
biib-2018331x10q.htm Edgar Link pending
biib-2018331xex101.htm Edgar Link pending
biib-2018331xex102.htm Edgar Link pending
biib-2018331xex103.htm Edgar Link pending
biib-2018331xex104.htm Edgar Link pending
biib-2018331xex311.htm Edgar Link pending
biib-2018331xex312.htm Edgar Link pending
biib-2018331xex321.htm Edgar Link pending
biogenlogostandarda12.jpg Edgar Link pending
biogenlogostandarda15.jpg Edgar Link pending
biosimilars.jpg Edgar Link pending
collabprofitshare.jpg Edgar Link pending
costofsales.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
financialhighlights.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gainlossonfvcontcons.jpg Edgar Link pending
incometaxprovision.jpg Edgar Link pending
interferon.jpg Edgar Link pending
oie.jpg Edgar Link pending
otherrevenues.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
rd.jpg Edgar Link pending
rdpiechart2017.jpg Edgar Link pending
rdpiechart2018.jpg Edgar Link pending
report.css Edgar Link pending
reserves.jpg Edgar Link pending
restructuring.jpg Edgar Link pending
sga.jpg Edgar Link pending
Show.js Edgar Link pending
spinraza.jpg Edgar Link pending
tecfidera.jpg Edgar Link pending
tysabri.jpg Edgar Link pending
zinbryta.jpg Edgar Link pending